Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-HIRA Antibody (R1Y85)

Catalog #:   RHF02201 Specific References (49) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: FCM, IF, IP, WB
Accession: P54198
Overview

Catalog No.

RHF02201

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

FCM: 1:20-1:100, IF: 1:50-1:200, IP: 1:20-1:50, WB: 1:1000-1:2000

Target

DGCR1, TUP1-like enhancer of split protein 1, Protein HIRA, HIR, TUPLE1, HIRA

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P54198

Applications

FCM, IF, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1Y85

Data Image
  • Western blot
    Western blot analysis of HIRA expression in HeLa cell lysate.
References

ICOS+CD4+ T cells define a high susceptibility to anti-PD-1 therapy-induced lung pathogenesis., PMID:40198121

Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort study., PMID:40116970

Bispecific antibody toxicities., PMID:39993816

Treatment of elderly and frail myeloma patients., PMID:39674493

Clinical characteristics of toxoplasmosis patients in Korea: A retrospective study using health insurance review and assessment service data and electronic medical records., PMID:39622654

Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective study., PMID:39192314

Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis., PMID:38769252

Activation-induced cytidine deaminase an antibody diversification enzyme interacts with chromatin modifier UBN1 in B-cells., PMID:37949972

Citrullinated fibrinogen-SAAs complex causes vascular metastagenesis., PMID:37620307

Serum Concentrations of Infliximab and IL-6 for Predicting One-Year Discontinuation of Infliximab Treatment Owing to Secondary Non-response in Patients with Rheumatoid Arthritis., PMID:37532562

Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges., PMID:36560614

Potential Association of Isolated γ-Glutamyltransferase Elevation with Incident Ischemic Heart Disease in Lean Koreans., PMID:36556187

Risk of acute myocardial infarction, stroke, and venous thromboembolism among patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in South Korea: A nationwide population-based study., PMID:36423779

N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4., PMID:35986123

The role of HIRA-dependent H3.3 deposition and its modifications in the somatic hypermutation of immunoglobulin variable regions., PMID:34873043

Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid and antibody tests up to 22 August 2020., PMID:34763752

Thymoma originating from the cervical component of the thymus in a degu., PMID:34515595

Central 22q11.2 deletion (LCR22 B-D) in a fetus with severe fetal growth restriction and a mother with severe systemic lupus erythematosus: Further evidence of CRKL haploinsufficiency in the pathogenesis of 22q11.2 deletion syndrome., PMID:34196458

Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications., PMID:33803400

Cerebral artery dissection secondary to antiphospholipid syndrome: A report of two cases and a literature review., PMID:33016197

Systematic review of literature and analysis of big data from the National Health Insurance System on primary immunodeficiencies in Korea., PMID:32683811

Collagen-An Important Fish Allergen for Improved Diagnosis., PMID:32389794

Thyroid Dysfunction Related to the Antiangiogenic VEGFR2-Binding Monoclonal Antibody Ramucirumab: A Series of 14 Cases and a Descriptive Study., PMID:32238718

Epidemiology of Antiphospholipid Syndrome in Korea: a Nationwide Population-based Study., PMID:32030922

Microscopic polyangiitis associated with thymic tumor: a case report and review of the literature., PMID:30961527

Comparison of different methodologies and cryostat versus paraffin sections for chromogenic immunohistochemistry., PMID:30454859

Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study., PMID:30290786

TGF-β1 promotes expression of fibrosis-related genes through the induction of histone variant H3.3 and histone chaperone HIRA., PMID:30232404

Impact of Adding Bevacizumab to Paclitaxel + Carboplatin for Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Propensity Score Matching Analysis., PMID:30191541

Recurrent Small Cell Carcinoma of the Uterine Cervix Responding to Combined Therapy with Paclitaxel, Cisplatin, and Bevacizumab: A Case Report., PMID:30191540

Estimation of cost savings between 2011 and 2014 attributed to infliximab biosimilar in the South Korean healthcare market: real-world evidence using a nationwide database., PMID:29667324

Common Variable Immunodeficiency Caused by FANC Mutations., PMID:28493158

Bilateral renal hilar tumors in IgG4-related disease., PMID:28321597

Human Tick-Borne Encephalitis, the Netherlands., PMID:27938522

Single cell biology beyond the era of antibodies: relevance, challenges, and promises in biomedical research., PMID:27714408

CRISPR/Cas9 Targets Chicken Embryonic Somatic Cells In Vitro and In Vivo and generates Phenotypic Abnormalities., PMID:27694906

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy., PMID:27646942

Differential regulation of the histone chaperone HIRA during muscle cell differentiation by a phosphorylation switch., PMID:27515126

Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis., PMID:27251675

P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer., PMID:26923603

Live detection and purification of cells based on the expression of a histone chaperone, HIRA, using a binding peptide., PMID:26596463

Quantification of Sorafenib in Human Serum by Competitive Enzyme-Linked Immunosorbent Assay., PMID:26521829

Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198., PMID:26363012

Histone Chaperone HIRA in Regulation of Transcription Factor RUNX1., PMID:25847244

Cellular therapy by allogeneic macrophages against visceral leishmaniasis: role of TNF-α., PMID:24996013

Genetically encoded system to track histone modification in vivo., PMID:23942372

Bilateral facial nerve palsy due to otitis media associated with myeloperoxidase-antineutrophil cytoplasmic antibody., PMID:23470272

Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation., PMID:22802343

Daikenchuto (TU-100) ameliorates colon microvascular dysfunction via endogenous adrenomedullin in Crohn's disease rat model., PMID:21808981

Datasheet

Document Download

Anti-HIRA Antibody (R1Y85).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-HIRA Antibody (R1Y85) [RHF02201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only